Hypertension, Vol 12, 474-478, Copyright © 1988 by American Heart Association
S Pontremoli, E Melloni, B Sparatore, F Salamino, R Pontremoli, A Tizianello, C Barlassina, D Cusi, R Colombo and G Bianchi
The calpain-calpain inhibitor system was evaluated in erythrocytes of
patients with essential hypertension and normotensive controls, either with
or without a family history of hypertension. Calpain levels were similar in
the controls and hypertensive patients, whereas the inhibitor activity
level was significantly reduced in the latter (301.8 +/- 26.4 vs 220 +/- 14
U/mg hemoglobin, p less than 0.001). Borderline hypertensive patients and a
few controls with a history of hypertension showed low inhibitor activity.
Similar results have recently been reported in genetically hypertensive
rats of the Milan strain. A significant inverse correlation (r = -0.43, p
less than 0.001) was found between mean arterial pressure and calpain
inhibitor. Although the pathophysiological significance of these
observations is not yet clear, they suggest a new area of investigation
into the molecular mechanisms underlying essential hypertension and its
complications.
ARTICLES
Erythrocyte deficiency in calpain inhibitor activity in essential hypertension
Istituto di Chimica Biologica, Universita di Genova, Italy.
This article has been cited by other articles:
![]() |
D. Polak-Jonkisz, L. Purzyc, K. Laszki-Szczachor, K. Musial, and D. Zwolinska The endogenous modulators of Ca2+-Mg2+-dependent ATPase in children with chronic kidney disease (CKD) Nephrol. Dial. Transplant., November 6, 2009; (2009) gfp436v2. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |